Seagen Inc. (NASDAQ: SGEN) is 51.30% higher on its value in year-to-date trading and has touched a low of $116.08 and a high of $207.16 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SGEN stock was last observed hovering at around $195.42 in the last trading session, with the day’s loss setting it -0.98% off its average median price target of $229.00 for the next 12 months. It is also 15.09% off the consensus price target high of $229.00 offered by 19 analysts, but current levels are -27.08% lower than the price target low of $153.00 for the same period.
Currently trading at $194.44, the stock is -1.46% and -3.05% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.85 million and changing -0.50% at the moment leaves the stock 24.06% off its SMA200. SGEN registered 45.68% gain for a year compared to 6-month gain of 56.14%. The firm has a 50-day simple moving average (SMA 50) of $18.40 and a 200-day simple moving average (SMA200) of -$68.01.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
The stock witnessed a -3.45% loss in the last 1 month and extending the period to 3 months gives it a 20.49%, and is 0.15% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.20% over the week and 1.19% over the month.
Seagen Inc. (SGEN) has around 3256 employees, a market worth around $36.62B and $2.06B in sales. Profit margin for the company is -31.50%. Distance from 52-week low is 67.51% and -6.14% from its 52-week high. The company has generated returns on investments over the last 12 months (-22.10%).
Seagen Inc. (SGEN) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Seagen Inc. (SGEN) is a “Overweight”. 19 analysts offering their recommendations for the stock have an average rating of 2.60, where 14 rate it as a Hold and 0 think it is a “Overweight”. 5 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Seagen Inc. is expected to release its quarterly report on 07/27/2023.The EPS is expected to grow by 10.80% this year
Seagen Inc. (SGEN) Top Institutional Holders
The shares outstanding are 186.89M, and float is at 183.63M with Short Float at 3.48%.
Seagen Inc. (SGEN) Insider Activity
A total of 122 insider transactions have happened at Seagen Inc. (SGEN) in the last six months, with sales accounting for 74 and purchases happening 48 times. The most recent transaction is an insider sale by ROMP CHARLES R, the company’s EVP, Commercial U.S. SEC filings show that ROMP CHARLES R sold 349 shares of the company’s common stock on May 16 at a price of $189.86 per share for a total of $66261.0. Following the sale, the insider now owns 59777.0 shares.
Seagen Inc. disclosed in a document filed with the SEC on May 15 that WELCH DANIEL G (Director) sold a total of 1,864 shares of the company’s common stock. The trade occurred on May 15 and was made at $200.02 per share for $0.37 million. Following the transaction, the insider now directly holds 6253.0 shares of the SGEN stock.
Still, SEC filings show that on May 02, WELCH DANIEL G (Director) disposed off 8,872 shares at an average price of $200.07 for $1.78 million. The insider now directly holds 6,253 shares of Seagen Inc. (SGEN).
Seagen Inc. (SGEN): Who are the competitors?
The company’s main competitors (and peers) include Rogers Corporation (ROG) that is trading -39.49% down over the past 12 months. AbbVie Inc. (ABBV) is -7.04% down on the 1-year trading charts.